Evidence map›Paper›PMID 37140702›Full record

ArticleEuropean journal of pediatrics2023

Epidemiology and clinical features of Streptococcus pyogenes bloodstream infections in children in Madrid, Spain.

Elvira Cobo-Vázquez, David Aguilera-Alonso, Tania Carbayo, Lucía M Figueroa-Ospina, Francisco Sanz-Santaeufemia, Fernando Baquero-Artigao, Carmen Vázquez-Ordoñez, Jaime Carrasco-Colom, Daniel Blázquez-Gamero, Beatriz Jiménez-Montero and 11 more

Abstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in European journal of pediatrics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
7.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 25 citations in OpenAlex.

  1. The Clinical Significance ofOpen forum infectious diseases · 2026
    Article
  2. Epidemiology of Pediatric Invasive Group A Streptococcal Infections in 10 US States, 2004-2023.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2026
    Article
  3. Review
  4. Article
  5. Role of viral coinfection in post-pandemic invasive Group A streptococcal infections in adults, a nation-wide cohort study (iGASWISS).European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2025
    Article
  6. Severe invasiveJournal of intensive medicine · 2025
    Article
  7. Article
  8. Article
  9. Invasive group A Streptococcus infection (Streptococcus pyogenes): Current situation in Spain.Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia · 2024
    Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Group A Streptococcus invasive infection in children: Epidemiologic changes and implications.Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia · 2023
    Review
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 18 institutions in 1 country.

Elvira Cobo-VázquezDepartment of Pediatrics, Hospital Universitario Fundación de Alcorcón, Servicio de Pediatría, Calle Budapest Nº1, 28922, Alcorcón, Madrid, Spain.
David Aguilera-AlonsoPhD Program in Medicine, Universidad Complutense de Madrid, Madrid, Spain. david.aguilera@salud.madrid.org.
Tania CarbayoDepartment of Neonatology, Hospital Universitario, 12 de Octubre, Madrid, Spain.
Lucía M Figueroa-OspinaDepartment of Pediatrics, Hospital General de Villalba, Villalba, Madrid, Spain.
Francisco Sanz-SantaeufemiaDepartment of Pediatrics, Hospital Universitario Niño Jesús, Madrid, Spain.
Fernando Baquero-ArtigaoDepartment of Infectious Diseases and Tropical Pediatrics, Hospital Universitario La Paz and IdiPaz Foundation, Madrid, Spain.
Carmen Vázquez-OrdoñezDepartment of Pediatrics, Hospital, Universitario Ramón y Cajal, Madrid, Spain.
Jaime Carrasco-ColomPediatric Infectious Diseases Unit, Department of Pediatrics, Hospital Universitario La Moraleja, Madrid, Spain.
Daniel Blázquez-GameroPediatric Infectious Diseases Unit, Department of Pediatrics, Hospital Universitario 12 de Octubre, Instituto de Investigación Hospital 12 de Octubre (imas12). Universidad Complutense, RITIP, Madrid, Spain.
Beatriz Jiménez-MonteroDepartment of Pediatrics, Hospital Clínico San Carlos, Madrid, Spain.
Carlos Grasa-LozanoDepartment of Infectious Diseases and Tropical Pediatrics, Hospital Universitario La Paz and IdiPaz Foundation, Madrid, Spain.
María José CillerueloDepartment of Pediatrics, Hospital Universitario Puerta de Hierro, Majadahonda, Madrid, Spain.
Ana ÁlvarezDepartment of Pediatrics, Hospital Universitario de Getafe, Getafe, Madrid, Spain.
Cristina Comín-CabreraDepartment of Pediatrics, Hospital Universitario de Torrejón, Torrejón de Ardoz, Madrid, Spain.
María PeninDepartment of Pediatrics, Hospital, Universitario Príncipe de Asturias, Alcalá de Henares, Madrid, Spain.
Emilia CercenadoMicrobiology and Infectious Diseases Department, Hospital General Universitario Gregorio Marañón, CIBER de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain.
Rut Del ValleDepartment of Pediatrics, Hospital Universitario Infanta Sofía, San Sebastián de los Reyes, Madrid, Spain.
Miguel Ángel RoaDepartment of Pediatrics, Hospital Universitario de Móstoles, Móstoles, Madrid, Spain.
Irene García-De DiegoDepartment of Pediatrics, Hospital Universitario del Tajo, Aranjuez, Madrid, Spain.
Cristina Calvo *Department of Infectious Diseases and Tropical Pediatrics, Hospital Universitario La Paz and IdiPaz Foundation, Madrid, Spain.
Jesús Saavedra-Lozano *Pediatric Infectious Diseases Unit, Department of Pediatrics, Hospital General Universitario Gregorio Marañón, CIBER de enfermedades infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Universidad Complutense, Madrid, Spain.
Hospital General Universitario Gregorio Marañón · ESCentro de Investigación Biomédica en Red · ESHospital Clínico San Carlos · ESHospital General de La Rioja · ESHospital Infantil Universitario Niño Jesús · ESHospital Universitario 12 De Octubre · ESHospital Universitario de Fuenlabrada · ESHospital Universitario de Getafe · ESHospital Universitario del Tajo · ESHospital Universitario de Móstoles · ESHospital Universitario de Torrejón · ESHospital Universitario Fundación Alcorcón · ESHospital Universitario Infanta Sofía · ESHospital Universitario La Paz · ESHospital Universitario Príncipe de Asturias · ESHospital Universitario Puerta de Hierro Majadahonda · ESHospital Universitario Ramón y Cajal · ESResearch Institute Hospital 12 de Octubre · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Studies have shown increased invasive Group A Streptococcus (GAS) disease, including bloodstream infections (GAS-BSI). However, the epidemiological data of GAS-BSI are limited in children. We aimed to describe GAS-BSI in children in Madrid, over 13 years (2005-2017). Multicenter retrospective cohort study from 16 hospitals from Madrid, Spain. Epidemiology, symptomatology, laboratory, treatment, and outcome of GAS-BSI in children ≤ 16 years were analyzed. 109 cases of GAS-BSI were included, with incidence rate of 4.3 episodes/100,000 children attended at the emergency department/year. We compared incidence between two periods (P1: 2005-June 2011 vs P2: July 2011-2017) and observed a non-significant increase along the study period (annual percentage change: + 6.0% [95%CI: -2.7, + 15.4]; p = 0.163). Median age was 24.1 months (IQR: 14.0-53.7), peaking during the first four years of life (89/109 cases; 81.6%). Primary BSI (46.8%), skin and soft tissue (21.1%), and osteoarticular infections (18.3%) were the most common syndromes. We compared children with primary BSI with those with a known source and observed that the former had shorter hospital stay (7 vs. 13 days; p = 0.003) and received intravenous antibiotics less frequently (72.5% vs. 94.8%; p = 0.001) and for shorter duration of total antibiotic therapy (10 vs. 21 days; p = 0.001). 22% of cases required PICU admission. Factors associated with severity were respiratory distress, pneumonia, thrombocytopenia, and surgery, but in multivariate analysis, only respiratory distress remained significant (adjusted OR:9.23 [95%CI: 2.16-29.41]). Two children (1.8%) died.   Conclusion: We observed an increasing, although non-significant, trend of GAS-BSI incidence within the study. Younger children were more frequently involved, and primary BSI was the most common and less severe syndrome. PICU admission was frequent, being respiratory distress the main risk factor. What is known: • In recent decades, several reports have shown a worldwide increase in the incidence of invasive Group A streptococcal disease (GAS), including bloodstream infection (BSI). Recently, there have been a few reports showing an increase in severity as well. • There needs to be more information on the epidemiology in children since most studies predominantly include adults. What is new: • This study, carried out in children with GAS-BSI in Madrid, shows that GAS-BSI affects mostly younger children, with a broad spectrum of manifestations, needing PICU admission frequently. Respiratory distress was the leading risk factor for severity, whereas primary BSI seemed to be less severe. • We observed an increasing, although non-significant, trend of GAS-BSI incidence in recent years (2005-2017).

Indexed as

BacteremiaRespiratory Distress SyndromeSepsisAdultChildChild, PreschoolHumansRetrospective StudiesRisk FactorsSpainStreptococcus pyogenesBacteremiaBloodstream infectionChildrenGroup A StreptococcusStreptococcus pyogenes

Identifiers

PMID37140702
OpenAlexW4368356289

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.